Marshall Wace’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-606,459
| Closed | -$23.9M | – | 2883 |
|
|
2023
Q2 | $23.9M | Buy |
606,459
+536,361
| +765% | +$18.9M | 0.05% | 417 |
|
|
2023
Q1 | $1.71M | Buy |
+70,098
| New | +$1.53M | ﹤0.01% | 1537 |
|
|
2022
Q3 | – | Sell |
-136,875
| Closed | -$1.32M | – | 3951 |
|
|
2022
Q2 | $1.32M | Buy |
+136,875
| New | +$1.72M | ﹤0.01% | 2277 |
|
|
2022
Q1 | – | Sell |
-1,133
| Closed | -$18K | – | 4261 |
|
|
2021
Q4 | $18K | Sell |
1,133
-33,266
| -97% | -$545K | ﹤0.01% | 3717 |
|
|
2021
Q3 | $559K | Buy |
+34,399
| New | +$374K | ﹤0.01% | 2329 |
|
|
2016
Q3 | – | Sell |
-117,872
| Closed | -$6.02M | – | 1182 |
|
|
2016
Q2 | $6.02M | Sell |
117,872
-21,426
| -15% | -$1.06M | 0.05% | 352 |
|
|
2016
Q1 | $5.89M | Buy |
139,298
+21,334
| +18% | +$1.09M | 0.06% | 314 |
|
|
2015
Q4 | $9.26M | Sell |
117,964
-46,483
| -28% | -$2.69M | 0.09% | 243 |
|
|
2015
Q3 | $6.66M | Buy |
164,447
+105,303
| +178% | +$5.58M | 0.08% | 245 |
|
|
2015
Q2 | $3.08M | Buy |
+59,144
| New | +$2.94M | 0.04% | 384 |
|
|
2015
Q1 | – | Sell |
-68,470
| Closed | -$3.07M | – | 967 |
|
|
2014
Q4 | $3.07M | Buy |
+68,470
| New | +$2.88M | 0.04% | 389 |
|
|
2014
Q2 | – | Sell |
-8,400
| Closed | -$300K | – | 1106 |
|
|
2014
Q1 | $300K | Buy |
+8,400
| New | +$283K | 0.01% | 703 |
|
Marshall Wace's ISEE Position: Q3 2023 in Review
Marshall Wace sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 606,459 shares — an estimated $23.9M sold.
Marshall Wace first reported a position in ISEE in Q1 2014 and held it in 12 quarters. The position peaked at $23.9M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.
- Marshall Wace reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Marshall Wace sold 606,459 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $23.9M.
- Marshall Wace first reported a position in IVERIC bio, Inc. Common Stock in Q1 2014 and held it in 12 quarters.
- Marshall Wace's IVERIC bio, Inc. Common Stock position peaked at $23.9M in Q2 2023.
- 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.
Based on Marshall Wace's 13F filing for Q3 2023, filed 14 Nov 2023.